Related references
Note: Only part of the references are listed.Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Anabela S. Ramalho et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants
Onofrio Laselva et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
How to determine the mechanism of action of CFTR modulator compounds: A gateway to theranostics
Margarida D. Amaral
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Rescue of multiple class II CFTR mutations by elexacaftor plus tezacaftor plus ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator
Onofrio Laselva et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action
Onofrio Laselva et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel
Nicoletta Pedemonte et al.
SCIENCE ADVANCES (2020)
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Miqueias Lopes-Pacheco
FRONTIERS IN PHARMACOLOGY (2020)
Lung function and microbiota diversity in cystic fibrosis
Leah Cuthbertson et al.
MICROBIOME (2020)
The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can be Rescued by Ivacaftor
Onofrio Laselva et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
Paolo Scudieri et al.
CELLS (2020)
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
Guido Veit et al.
JCI INSIGHT (2020)
An open-source high-content analysis workflow for CFTR function measurements using the forskolin-induced swelling assay
Marne C. Hagemeijer et al.
BIOINFORMATICS (2020)
Assessment of Distinct Electrophysiological Parameters in Rectal Biopsies for the Choice of the Best Diagnosis/Prognosis Biomarkers for Cystic Fibrosis
Iris A. L. Silva et al.
FRONTIERS IN PHYSIOLOGY (2020)
Preclinical Studies of a Rare CF-Causing Mutation in the Second Nucleotide Binding Domain (c.3700A>G) Show Robust Functional Rescue in Primary Nasal Cultures by Novel CFTR Modulators
Onofrio Laselva et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids
Annelotte M. Vonk et al.
STAR PROTOCOLS (2020)
Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A > G
Iris A. L. Silva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
R560S: A class II CFTR mutation that is not rescued by current modulators
Nikhil T. Awatade et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Cystic fibrosis - an example of personalized and precision medicine
Marianne Skov et al.
APMIS (2019)
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality
Felice Amato et al.
HUMAN MUTATION (2019)
Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis
Gitte Berkers et al.
CELL REPORTS (2019)
Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
Iwona Pranke et al.
FRONTIERS IN PHARMACOLOGY (2019)
Intestinal organoids to model cystic fibrosis
Peter van Mourik et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel
Yu-Sheng Wu et al.
MOLECULAR PHARMACOLOGY (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Microbiology of Cystic Fibrosis Airway Disease
Ana C. Blanchard et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations
Misak Harutyunyan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function
Karin M. de Winter-de Groot et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Guido Veit et al.
NATURE MEDICINE (2018)
Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies
John J. Brewington et al.
JCI INSIGHT (2018)
Personalized or Precision Medicine? The Example of Cystic Fibrosis
Fernando A. L. Marson et al.
FRONTIERS IN PHARMACOLOGY (2017)
Orkambi® and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissue
Steven V. Molinski et al.
EMBO MOLECULAR MEDICINE (2017)
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
Johanna F. Dekkers et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Progress in therapies for cystic fibrosis
Kris De Boeck et al.
LANCET RESPIRATORY MEDICINE (2016)
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Andre M. Cantin et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Personalized medicine for cystic fibrosis: Establishing human model systems
Hongmei Mou et al.
PEDIATRIC PULMONOLOGY (2015)
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis
Nikhil T. Awatade et al.
EBIOMEDICINE (2015)
Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility
Maria F. Servidoni et al.
BMC GASTROENTEROLOGY (2013)
Measurements of CFTR-Mediated Cl- Secretion in Human Rectal Biopsies Constitute a Robust Biomarker for Cystic Fibrosis Diagnosis and Prognosis
Marisa Sousa et al.
PLOS ONE (2012)
Regulation of Electroneutral NaCl Absorption by the Small Intestine
Akira Kato et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
The K+ Channel Opener 1-EBIO Potentiates Residual Function of Mutant CFTR in Rectal Biopsies from Cystic Fibrosis Patients
Eva K. Roth et al.
PLOS ONE (2011)
CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis
S Hirtz et al.
GASTROENTEROLOGY (2004)
Share Paper
